Zeno Health, an omni-channel platform for quality and affordable generic medicines, has appointed K2 Communications Pvt. Ltd. as its communication partner. The legacy firm has been instrumental in announcing the brand’s securement of $25 million in Series C funding last month.
Kush Jain, Head of Growth at Zeno Health, said, “Zeno Health has been in search of a trusted partner with a proven track record in our niche to initiate our communication journey. K2 Communications is renowned and respected for their innovative and out-of-the-box ideas.
“They also have a dedicated vertical team for health care sector and this works in our favor. Moreover, the healthcare sector, and especially the pharmaceutical market in India, is poised for a revolution in the coming years.
“We believe this is the opportune moment to accelerate our efforts in educating the masses about generic medicine. K2’s approach aligns with our objectives, and we are delighted to have them on board. We are confident that our shared vision of democratizing healthcare in India will soon become a reality,” Jain said.
In this new collaboration, K2 Communications will collaborate closely with Zeno Health’s Corporate Communications and Marketing team to implement strategies aimed at enhancing the company’s brand positioning within the healthcare and pharmaceutical sectors in India.
Shiv Shankar Devaraaj, Founder and CEO of K2 Communications, said, “While K2 Communications caters to various segments, it also specializes in healthcare and its ancillary sectors. In addition, we have a fully functional and adept Mumbai branch to cater to clients in the region. We have a legacy of 21 years and most of our clients have been with us since the beginning.
“We are grateful to Siddharth Gadia, CEO and Co-Founder and Mr. Girish Agrawal, Founder of Zeno Health for reposing their faith in us. We are committed to seeing them achieve their goals using grounded PR narratives that will sync with the pulse of all stakeholders,” Devaraaj added.